This site is intended for health professionals only

At the heart of general practice since 1960

Warning over too-aggressive diabetes care

The latest guidance from the National Prescribing Centre has warned GPs against aggressively treating patients with type 2 diabetes to extremely low blood sugar targets.

The April MeReC update assessed the evidence from the abandoned intensive treatment arm of the ACCORD trial , which was abandoned after patients treated to less than 6.0% HbA1c had a 27% higher relative risk of death. The update concluded that GPs should avoid intensive lowering of blood sugar targets, as ‘the evidence indicates that the benefits of intensive control of blood glucose may be less than some patients and healthcare professional perceive.'

Rate this article 

Click to rate

  • 1 star out of 5
  • 2 stars out of 5
  • 3 stars out of 5
  • 4 stars out of 5
  • 5 stars out of 5

0 out of 5 stars

Have your say